Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis . Mediterr J Hematol Infect Dis [Internet]. 2024 Apr. 30 [cited 2026 Feb. 16];16(1):e2024047. Available from: https://www.mjhid.org/mjhid/article/view/5697